Cellectar Biosciences P/CF Ratio 2011-2026 | CLRB

Annual P/CF Ratio Cellectar Biosciences

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-0.324	-0.0736	-1.37	-0.473	-0.148	-420	-1.74	-0.506	-1.53	-0.858	-0.52	-1.24	-2.45	-4.36	-1.64

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-0.0736	-420	-29.2

P/CF Ratio of other stocks in the Biotechnology industry

Issuer	P/CF Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	-0.654	-	2.43 %	$ 254 M	Germany
ARCA biopharma ABIO	-8.36	-	1052.0 %	$ 415 M	USA
Verastem VSTM	-2.94	$ 5.04	-4.73 %	$ 349 M	USA
VistaGen Therapeutics VTGN	-1.75	$ 0.57	-5.87 %	$ 17.6 M	USA
Aeterna Zentaris AEZS	-4.82	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	-0.0018	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	-4.6	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	-1.3	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	-2.7	-	0.23 %	$ 488 M	USA
Akero Therapeutics AKRO	-14.1	-	-	$ 3.67 B	USA
I-Mab IMAB	-0.266	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	11.6	-	-	$ 40.3 B	USA
Genfit SA GNFT	1.68 K	-	2.54 %	$ 160 B	France
Albireo Pharma ALBO	-5	-	-0.23 %	$ 916 M	USA
Biophytis SA BPTS	-23.1	-	-13.47 %	$ 169 M	France
Aileron Therapeutics ALRN	-1.71	-	10.36 %	$ 9.8 M	USA
Aptinyx APTX	-0.159	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	-13.2	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	-3.88	-	-1.52 %	$ 24.7 M	USA
Arena Pharmaceuticals ARNA	-12.5	-	-6.81 %	$ 3.04 B	USA
Applied Genetic Technologies Corporation AGTC	-0.64	-	-	$ 26.5 M	USA
Avenue Therapeutics ATXI	-0.0603	-	-52.27 %	$ 4.45 M	USA
Ayala Pharmaceuticals AYLA	-0.224	-	-	$ 7.46 M	Israel
Atreca BCEL	-0.607	-	-11.76 %	$ 5.79 M	USA
Acorda Therapeutics ACOR	-1.2	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	-0.285	-	-	$ 546 M	USA
Acasti Pharma ACST	-2.73	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	-89	-	-	-	Russia
Avid Bioservices CDMO	38.7	-	-	$ 789 M	USA
Adverum Biotechnologies ADVM	-0.826	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	-0.401	-	2.71 %	$ 14 M	USA
Advaxis ADXS	-0.0633	-	-9.65 %	$ 45.9 M	USA
Adaptive Biotechnologies Corporation ADPT	-54	$ 12.41	-11.1 %	$ 1.88 B	USA
BeiGene, Ltd. BGNE	-1.8 K	-	0.49 %	$ 251 B	Cayman-islands
BioDelivery Sciences International BDSI	7.5	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	-0.588	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	-0.024	-	-	$ 3.74 B	USA
Enlivex Therapeutics Ltd. ENLV	-1.4	$ 1.05	-3.67 %	$ 21.5 M	Israel
Enochian Biosciences ENOB	-14.7	-	-	$ 40.5 M	USA
CureVac N.V. CVAC	-4.82	-	-	$ 867 M	Germany
Summit Therapeutics SMMT	-37.2	$ 16.58	-3.94 %	$ 12.4 B	Britain
Zymeworks ZYME	-4.39	$ 24.18	-2.07 %	$ 1.25 B	Canada
AbbVie ABBV	21	$ 209.4	-0.83 %	$ 370 B	USA
AbCellera Biologics ABCL	-7.33	$ 3.27	-2.39 %	$ 977 M	Canada
Bellerophon Therapeutics BLPH	-4.42	-	-74.18 %	$ 955 K	USA
Altimmune ALT	-4.71	$ 3.02	-5.63 %	$ 266 M	USA
Autolus Therapeutics plc AUTL	-2.05	$ 1.21	-6.2 %	$ 309 M	Britain
Alnylam Pharmaceuticals ALNY	77.9	$ 317.36	-3.29 %	$ 41.6 B	USA
Aytu BioScience AYTU	-8.14	$ 2.6	-2.8 %	$ 16.3 M	USA
Arbutus Biopharma Corporation ABUS	-21.4	$ 4.29	-3.6 %	$ 822 M	Canada